Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.48B |
| 2 |
NVIDIA
NVDA
|
+$782M |
| 3 |
Amazon
AMZN
|
+$657M |
| 4 |
Walt Disney
DIS
|
+$572M |
| 5 |
Advanced Micro Devices
AMD
|
+$517M |
Top Sells
| 1 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$1.41B |
| 2 |
Palo Alto Networks
PANW
|
+$708M |
| 3 |
Boston Scientific
BSX
|
+$704M |
| 4 |
Comcast
CMCSA
|
+$673M |
| 5 |
T-Mobile US
TMUS
|
+$625M |
Sector Composition
| 1 | Technology | 19.27% |
| 2 | Healthcare | 14.85% |
| 3 | Financials | 10.95% |
| 4 | Consumer Discretionary | 10.86% |
| 5 | Industrials | 7.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGRX
5126
DELISTED
Agile Therapeutics, Inc
AGRX
| $37.5K | ﹤0.01% |
19,247
+6,422
| +50% | +$12.5K |
|
5127
OLB
OLB
$11M
| $37.2K | ﹤0.01% |
+3,505
| New | +$37.2K |
|
5128
Lexaria Bioscience
LEXX
$23.3M
| $37K | ﹤0.01% |
+29,561
| New | +$37K |
|
|
XYF
5129
X Financial
XYF
$579M
| $36.8K | ﹤0.01% |
10,057
-13,935
| -58% | -$51K |
|
|
STEX
5130
Streamex Corp. Common Stock
STEX
$221M
| $36.7K | ﹤0.01% |
+7,725
| New | +$36.7K |
|
5131
Lumen
LUMN
$6.21B
| $36.7K | ﹤0.01% |
+20,033
| New | +$36.7K |
|
|
RGLS
5132
DELISTED
Regulus Therapeutics
RGLS
| $36.4K | ﹤0.01% |
28,461
+16,746
| +143% | +$21.4K |
|
5133
InfuSystem Holdings
INFU
$204M
| $36.4K | ﹤0.01% |
3,453
-13,818
| -80% | -$146K |
|
5134
Rigel Pharmaceuticals
RIGL
$681M
| $36.2K | ﹤0.01% |
2,497
+2,280
| +1,051% | +$33.1K |
|
5135
Safety Insurance
SAFT
$1.1B
| $36.2K | ﹤0.01% |
476
-2,651
| -85% | -$201K |
|
5136
Ovid Therapeutics
OVID
$89.6M
| $36.1K | ﹤0.01% |
+11,202
| New | +$36.1K |
|
|
FHLTU
5137
DELISTED
Future Health ESG Corp. Unit
FHLTU
| $36K | ﹤0.01% |
107,378
| – | – |
|
|
KA
5138
DELISTED
Kineta, Inc. Common Stock
KA
| $35.6K | ﹤0.01% |
+10,015
| New | +$35.6K |
|
|
PPTA
5139
Perpetua Resources
PPTA
$1.86B
| $35.5K | ﹤0.01% |
11,187
+8,775
| +364% | +$27.8K |
|
|
SVMH
5140
DELISTED
SRIVARU Holding Limited Ordinary Shares
SVMH
| $35.4K | ﹤0.01% |
+1,996
| New | +$35.4K |
|
5141
LENSAR
LNSR
$149M
| $35.4K | ﹤0.01% |
10,088
+1,126
| +13% | +$3.95K |
|
5142
Duos Technologies
DUOT
$155M
| $35.4K | ﹤0.01% |
12,293
-5,104
| -29% | -$14.7K |
|
5143
Purple Innovation
PRPL
$114M
| $35.4K | ﹤0.01% |
34,345
-7,589
| -18% | -$7.82K |
|
|
PEV
5144
DELISTED
Phoenix Motor Inc. Common Stock
PEV
| $35.3K | ﹤0.01% |
+33,983
| New | +$35.3K |
|
5145
FiscalNote
NOTE
$65.6M
| $35.1K | ﹤0.01% |
+2,562
| New | +$35.1K |
|
|
GRFX
5146
DELISTED
Graphex Group
GRFX
| $34.8K | ﹤0.01% |
+8,004
| New | +$34.8K |
|
5147
iBio
IBIO
$18.3M
| $34.8K | ﹤0.01% |
25,387
+25,384
| +846,133% | +$34.8K |
|
5148
Ondas Holdings
ONDS
$2.14B
| $34.8K | ﹤0.01% |
+22,721
| New | +$34.8K |
|
5149
Vision Marine Technologies
VMAR
$4.78M
| $34.4K | ﹤0.01% |
+23
| New | +$34.4K |
|
|
RAIN
5150
DELISTED
Rain Oncology Inc. Common Stock
RAIN
| $34.2K | ﹤0.01% |
28,491
+27,727
| +3,629% | +$33.3K |
|